Key Highlights

● Steris closed Friday at $264.32, up 4.29%, among the S&P 500's strongest performers.

● Jefferies upgraded the medical products company to buy from hold.

● Defensive sectors held up better as technology stocks fell on Friday.

● Hospital spending and procedure volumes are the key operating variables.

Steris (NYSE:STE) heads into the new week with fresh analyst support behind it. Market reports said that the stock gained nearly 4% after Jefferies (NYSE:JEF) upgraded the medical products company to buy from hold. Market data show Steris closed Friday, November 13, 2026, at $264.32, up 4.29%, among the strongest performers in the S&P 500 that day.

What the company does

Steris is a medical technology company best known for infection prevention and sterilization products and services used by hospitals, surgical centers and life-science manufacturers. That makes its Business more tied to procedure volumes and hospital spending than to the economic cycle or the AI build-out.

Why it stood out on Friday

Friday was a day of rotation. Technology stocks fell sharply as Nvidia (NASDAQ:NVDA)'s Leadership crisis and rising Treasury yields hit the AI trade, while more defensive groups held up better. A healthcare name with an analyst upgrade fit what investors were looking for. As an S&P 500 member, Steris benefits when money moves toward steady earners.

Risks and next steps for Steris

An upgrade-driven jump can fade if the broader market turns back toward Growth Stocks after Nvidia's Earnings on Tuesday. Hospital Capital spending and procedure volumes are the key operating variables for the company. There is no confirmed Steris-specific event on Monday's calendar, so the stock is likely to trade with healthcare and defensive sectors in the near term.